Everolimus (RAD001) in Primary Therapy of Waldenstrom's Macroglobulinemia
Status:
Completed
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine the safety of RAD001(Everolimus) and the
highest dose of this drug that can be given to people safely. RAD001(Everolimus) is a drug
that works by preventing cells in the body from growing and dividing. Information from basic
and Phase I clinical research studies suggests that RAD001 also may help to prevent tumor
growth in people with relapsed or refractory lymphoma.